Macquarie Group
CORZ icon

Macquarie Group’s Core Scientific CORZ Stock Holding History

Macquarie Group’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-152,964
Closed -$1.42M – 1716
2024
Q2 		$1.42M Buy
152,964
+143,692
+1,550% +$734K ﹤0.01% 1312
2024
Q1 		$33 Buy
+9,272
New +$32.2K ﹤0.01% 1667

Other funds holding CORZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OWP
ORG Wealth Partners Dallas, Texas $508M AUM 83.62% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
JCM
JAT Capital Management Greenwich, Connecticut $59.3M AUM 134.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group's CORZ Position: Q3 2024 in Review

Macquarie Group sold out of Core Scientific (CORZ) in Q3 2024, closing a stake of 152,964 shares — an estimated $1.42M sold.

Macquarie Group first reported a position in CORZ in Q1 2024 and held it in 2 quarters. The position peaked at $1.42M in Q2 2024. 249 funds tracked by Wall St. Rank hold CORZ as of Q3 2024.

  • Macquarie Group reported no remaining Core Scientific position as of Q3 2024 after selling out during the quarter.
  • Macquarie Group sold 152,964 Core Scientific shares in Q3 2024, an estimated $1.42M.
  • Macquarie Group first reported a position in Core Scientific in Q1 2024 and held it in 2 quarters.
  • Macquarie Group's Core Scientific position peaked at $1.42M in Q2 2024.
  • 249 funds tracked by Wall St. Rank held Core Scientific as of Q3 2024.

Based on Macquarie Group's 13F filing for Q3 2024, filed 14 Nov 2024.